Genetic variation in the ABCB1 gene associated with post treatment lyme disease syndrome status
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
Post Treatment Lyme Disease Syndrome (PTLDS) poses a difficult to understand health issue. This multi-centered, randomized control trial studied the possible correlation between ABCB1 (MDR1) gene variants and the incidence of PTLDS in affected patients. Genomic DNA was isolated and analyzed for four ABCB1 gene SNPs (rs1128503, rs1045642, rs2235067, and rs4148740). Significant findings include the association of rs1128503 TC variant with PTLDS status. Additionally, the rs1128503+ rs1045642+ rs2235067 SNP combination increased rs1128503 genotype TC significance to 3.83 times the rs1128503 genotype CC. The TT variant of rs4148740 in conjunction with rs1128503 reduced the odds ratio and appeared to convey a PTLDS protective status to the rs1128503 TC variant. Copyright 2019 The AuthorsSponsors
This study was funded by a research grant from the Lyme Disease Association , Inc.Keyword
ABCB1Genetics
Lyme disease
MDR1
P-glycoprotein (P-gp)
Post treatment lyme disease syndrome (PTLDS)
rs1045642
rs1128503
rs2235067
rs4148740
Single nucleotide polymorphism (SNP)
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066934446&doi=10.1016%2fj.mgene.2019.100589&partnerID=40&md5=5b15563b2a7b1f634a28ab103059d95a; http://hdl.handle.net/10713/10174ae974a485f413a2113503eed53cd6c53
10.1016/j.mgene.2019.100589